デフォルト表紙
市場調査レポート
商品コード
1621818

eクリニカルソリューション市場:製品別、市場開拓フェーズ別、提供形態別、エンドユーザー別-2025年~2030年の世界予測

eClinical Solutions Market by Product (Clinical Analytics Platforms, Clinical Data Integration Platforms, Clinical Trial Management Systems), Development Phase (Phase I, Phase II, Phase III), Delivery Mode, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 188 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
eクリニカルソリューション市場:製品別、市場開拓フェーズ別、提供形態別、エンドユーザー別-2025年~2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

eクリニカルソリューション市場の2023年の市場規模は90億8,000万米ドルで、2024年には103億1,000万米ドルに達すると予測され、2030年にはCAGR 13.96%で226億9,000万米ドルに成長すると予測されています。

eクリニカルソリューション市場には、電子データ収集(EDC)、臨床試験管理システム(CTMS)など、臨床試験やデータの管理を支援するための技術やソフトウェアが含まれています。これらのソリューションは、臨床研究の効率性と正確性を高めるために不可欠であり、紙ベースのシステムからデータ収集、モニタリング、分析を合理化するデジタルシステムへの移行を可能にします。eクリニカルソリューションの必要性は、臨床試験の複雑化、規制の強化、臨床データへのリアルタイムアクセスの必要性に起因しています。製薬、バイオテクノロジー、研究開発受託機関では、臨床試験データの管理、データ品質の向上、コスト削減、医薬品開発期間の短縮を実現するために、このアプリケーションは極めて重要です。主な成長要因としては、クラウドベースのソリューション採用の増加、臨床試験におけるウェアラブルデバイスやIoTデバイスの台頭、個別化医療の重視の高まりなどが挙げられます。人工知能と機械学習を活用して臨床試験における予測分析と意思決定プロセスを強化する機会は豊富にあります。こうした機会を捉えるために、組織は堅牢なデータ統合技術に投資し、ハイテク企業とのパートナーシップを構築すべきです。限界としては、データプライバシーに関する懸念、eクリニカルソリューションへの高額な初期投資、これらのソリューションとレガシーシステムとの統合の複雑さなどが挙げられます。規制上の課題や、地域によって異なる多様な要件も大きなハードルとなっています。同市場は、特にリアルタイムデータ分析、患者エンゲージメント技術、分散型臨床試験の領域において、イノベーションの展望に満ちています。ブロックチェーン統合の研究が進めば、改ざん防止された安全なデータ管理が実現する可能性があります。eクリニカルソリューション市場は、急速な技術進歩と高度な競合を特徴としており、各社は革新的な製品提供と戦略的提携に注力しています。全体として、患者中心のソリューションとスケーラブルで効率的なプラットフォームに注力することで、利害関係者は現在の課題に効果的に対処し、eクリニカルソリューション市場の将来の成長を促進することができます。

主な市場の統計
基準年[2023] 90億8,000万米ドル
予測年[2024] 103億1,000万米ドル
予測年[2030] 226億9,000万米ドル
CAGR(%) 13.96%

市場力学:急速に進化するeクリニカルソリューション市場の主要市場インサイトを公開

eクリニカルソリューション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 製薬・バイオファーマ企業による研究開発活動の活発化
    • 製薬セクターにおけるIoTとAIの統合の増加
    • 臨床試験に関する厳格な規制体制の存在
  • 市場抑制要因
    • eクリニカルソリューションの導入コストの高さ
  • 市場機会
    • 技術的に高度なeクリニカルソリューションのイントロダクション
    • eクリニカルソリューションへのソフトウェア搭載の増加
  • 市場の課題
    • eクリニカルソリューションに関連するソフトウェアの信頼性と特許プライバシーの問題

ポーターのファイブフォース:eクリニカルソリューション市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、eクリニカルソリューション市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:eクリニカルソリューション市場における外部からの影響の把握

外部マクロ環境要因は、eクリニカルソリューション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析eクリニカルソリューション市場における競合情勢の把握

eクリニカルソリューション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスeクリニカルソリューション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、eクリニカルソリューション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨eクリニカルソリューション市場における成功への道筋を描く

eクリニカルソリューション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製薬企業およびバイオ製薬企業による研究開発活動の増加
      • 製薬業界におけるIoTとAIの統合の拡大
      • 臨床試験に対する厳格な規制体制の存在
    • 抑制要因
      • eクリニカルソリューションの実装コストが高い
    • 機会
      • 技術的に高度なeクリニカルソリューションのイントロダクション
      • eクリニカルソリューションへのソフトウェアの組み込みの増加
    • 課題
      • eクリニカルソリューションに関連するソフトウェアの信頼性と特許プライバシーの問題
  • 市場セグメンテーション分析
    • 製品:臨床試験プロセス全体を通じてより良い意思決定を支援する臨床分析プラットフォームの採用が拡大
    • エンドユーザー:製薬およびバイオテクノロジー組織における大規模な複数サイトの試験の管理のためのeクリニカルソリューションの導入が増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 eクリニカルソリューション市場:製品別、市場:製品別

  • 臨床分析プラットフォーム
  • 臨床データ統合プラットフォーム
  • 臨床試験管理システム
  • 電子臨床結果評価
  • 電子同意
  • 電子データキャプチャと臨床データ管理システム
  • 電子裁判マスターファイル
  • ランダム化と治験供給管理
  • 安全ソリューション

第7章 eクリニカルソリューション市場:製品別、市場開発段階別

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第8章 eクリニカルソリューション市場:製品別、市場配送方法別

  • クラウド
  • オンプレミス

第9章 eクリニカルソリューション市場:製品別、市場:エンドユーザー別

  • 学術機関
  • 契約調査機関
  • 病院
  • 医療機器メーカー
  • 製薬・バイオテクノロジー企業

第10章 南北アメリカのeクリニカルソリューション市場:製品別、市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のeクリニカルソリューション市場:製品別、市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのeクリニカルソリューション市場:製品別、市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • Revvity Signals臨床ソリューションによる臨床試験データ管理の革新
    • Clarioがソフトウェアソリューション部門をSiteroに売却し、中核となる臨床技術に再び注力
    • 戦略的買収によりエンドツーエンドの臨床調査ソリューションが強化
    • Almac、スポンサーとCROの臨床試験管理を強化するiXRS3パートナーシップネットワークを発表
    • クリニオン、臨床試験における医療コーディングのためのAI駆動型ソリューションを導入
    • ResoluteAI、医薬品開発の効率を高める最先端の臨床試験分析プラットフォームを発表
  • 戦略分析と提言

企業一覧

  • 4G Clinical
  • Acceliant
  • Advarra, Inc.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • BSI Business Systems Integration AG
  • Castor Research Inc.
  • Clinion
  • Dassault Systemes S.E.
  • eClinical Solutions LLC
  • EvidentIQ Group GmbH
  • Fountayn
  • ICON PLC
  • International Business Machines Corporation
  • IQVIA Inc.
  • KPS Life, LLC
  • MaxisIT Inc.
  • MedNet Solutions, Inc.
  • Medrio, Inc.
  • Microsoft Corporation
  • Octalsoft
  • Oracle Corporation
  • Parexel International Corporation
  • RealTime Software Solutions, LLC
  • Research Solutions, Inc.
  • Saama Technologies, LLC
  • Signant Health
  • Sitero
  • Veeva Systems Inc.
図表

LIST OF FIGURES

  • FIGURE 1. ECLINICAL SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. ECLINICAL SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ECLINICAL SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ECLINICAL SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL ANALYTICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL DATA INTEGRATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC CLINICAL OUTCOME ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC CONSENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE & CLINICAL DATA MANAGEMENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ELECTRONIC TRIAL MASTER FILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY SAFETY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PHARMA & BIOTECH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ECLINICAL SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ECLINICAL SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 200. ECLINICAL SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-A339DAEFB0ED

The eClinical Solutions Market was valued at USD 9.08 billion in 2023, expected to reach USD 10.31 billion in 2024, and is projected to grow at a CAGR of 13.96%, to USD 22.69 billion by 2030.

The eClinical Solutions market encapsulates technologies and software designed to assist in the management of clinical trials and data, encompassing electronic data capture (EDC), clinical trial management systems (CTMS), and more. These solutions are vital for enhancing efficiency and accuracy in clinical research, enabling the shift from paper-based systems to digital systems that streamline data collection, monitoring, and analysis. The necessity for eClinical Solutions stems from the growing complexity of clinical trials, escalating regulatory pressures, and the need for real-time access to trial data. Their application is pivotal in pharmaceutical, biotechnology, and contract research organizations to manage trial data, improve data quality, and reduce costs while accelerating drug development timelines. Key growth factors include the increasing adoption of cloud-based solutions, the rise of wearable and IoT devices in clinical trials, and the growing emphasis on personalized medicine. Opportunities abound in leveraging artificial intelligence and machine learning to enhance predictive analytics and decision-making processes in trials. To seize these opportunities, organizations should invest in robust data integration technologies and develop partnerships with tech companies. Limitations include concerns about data privacy, the high initial investment in eClinical solutions, and the complexity of integrating these solutions with legacy systems. Regulatory challenges and the diverse requirements across different regions also pose significant hurdles. The market is ripe with innovation prospects, particularly in the domains of real-time data analytics, patient engagement technologies, and decentralized trials. Continued research in blockchain integration could provide secure, tamper-proof data management. The eClinical Solutions market is characterized by rapid technological advancements and a high degree of competition, prompting companies to focus on innovative product offerings and strategic collaborations. Overall, by focusing on patient-centric solutions and scalable, efficient platforms, stakeholders can effectively address current challenges and drive future growth in the eClinical Solutions market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.08 billion
Estimated Year [2024] USD 10.31 billion
Forecast Year [2030] USD 22.69 billion
CAGR (%) 13.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving eClinical Solutions Market

The eClinical Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising research and development activities by pharma and biopharma companies
    • Increasing integration of IoT and AI in the pharmaceutical sector
    • Presence of a stringent regulatory structure for clinical trials
  • Market Restraints
    • High cost of implementation of eClinical solutions
  • Market Opportunities
    • Introduction of technologically advanced eClinical solutions
    • Increasing incorporation of software in eClinical solutions
  • Market Challenges
    • Software reliability and patent privacy issues associated with eClinical solutions

Porter's Five Forces: A Strategic Tool for Navigating the eClinical Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the eClinical Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the eClinical Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the eClinical Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the eClinical Solutions Market

A detailed market share analysis in the eClinical Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the eClinical Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the eClinical Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the eClinical Solutions Market

A strategic analysis of the eClinical Solutions Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the eClinical Solutions Market, highlighting leading vendors and their innovative profiles. These include 4G Clinical, Acceliant, Advarra, Inc., Anju Software, Inc., ArisGlobal LLC, BSI Business Systems Integration AG, Castor Research Inc., Clinion, Dassault Systemes S.E., eClinical Solutions LLC, EvidentIQ Group GmbH, Fountayn, ICON PLC, International Business Machines Corporation, IQVIA Inc., KPS Life, LLC, MaxisIT Inc., MedNet Solutions, Inc., Medrio, Inc., Microsoft Corporation, Octalsoft, Oracle Corporation, Parexel International Corporation, RealTime Software Solutions, LLC, Research Solutions, Inc., Saama Technologies, LLC, Signant Health, Sitero, and Veeva Systems Inc..

Market Segmentation & Coverage

This research report categorizes the eClinical Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Clinical Analytics Platforms, Clinical Data Integration Platforms, Clinical Trial Management Systems, Electronic Clinical Outcome Assessment, Electronic Consent, Electronic Data Capture & Clinical Data Management Systems, Electronic Trial Master File, Randomization and Trial Supply Management, and Safety Solutions.
  • Based on Development Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Delivery Mode, market is studied across Cloud and On-premise.
  • Based on End-User, market is studied across Academic Institutes, Contract Research Organization, Hospitals, Medical Device Manufacturers, and Pharma & Biotech Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising research and development activities by pharma and biopharma companies
      • 5.1.1.2. Increasing integration of IoT and AI in the pharmaceutical sector
      • 5.1.1.3. Presence of a stringent regulatory structure for clinical trials
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of implementation of eClinical solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced eClinical solutions
      • 5.1.3.2. Increasing incorporation of software in eClinical solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Software reliability and patent privacy issues associated with eClinical solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing adoption of clinical analytics platforms to aid in better decision-making throughout the clinical trial process
    • 5.2.2. End-User: Rising deployment of eClinical solutions in pharma & biotech organizations to manage large-scale multi-site trials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. eClinical Solutions Market, by Product

  • 6.1. Introduction
  • 6.2. Clinical Analytics Platforms
  • 6.3. Clinical Data Integration Platforms
  • 6.4. Clinical Trial Management Systems
  • 6.5. Electronic Clinical Outcome Assessment
  • 6.6. Electronic Consent
  • 6.7. Electronic Data Capture & Clinical Data Management Systems
  • 6.8. Electronic Trial Master File
  • 6.9. Randomization and Trial Supply Management
  • 6.10. Safety Solutions

7. eClinical Solutions Market, by Development Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. eClinical Solutions Market, by Delivery Mode

  • 8.1. Introduction
  • 8.2. Cloud
  • 8.3. On-premise

9. eClinical Solutions Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Contract Research Organization
  • 9.4. Hospitals
  • 9.5. Medical Device Manufacturers
  • 9.6. Pharma & Biotech Organizations

10. Americas eClinical Solutions Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific eClinical Solutions Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa eClinical Solutions Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Revolutionizing Clinical Trial Data Management with Revvity Signals Clinical Solution
    • 13.3.2. Clario Divests Software Solutions Unit to Sitero, Refocusing on Core Clinical Technologies
    • 13.3.3. Strategic Acquisition Enhances End-to-End Clinical Research Solutions
    • 13.3.4. Almac Unveils iXRS3 Partnership Network to Enhance Clinical Trial Management for Sponsors and CROs
    • 13.3.5. Clinion Introduced AI-Driven Solution for Medical Coding in Clinical Trials
    • 13.3.6. ResoluteAI Unveils Cutting-Edge Clinical Trial Analytics Platform to Enhance Drug Development Efficiency
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4G Clinical
  • 2. Acceliant
  • 3. Advarra, Inc.
  • 4. Anju Software, Inc.
  • 5. ArisGlobal LLC
  • 6. BSI Business Systems Integration AG
  • 7. Castor Research Inc.
  • 8. Clinion
  • 9. Dassault Systemes S.E.
  • 10. eClinical Solutions LLC
  • 11. EvidentIQ Group GmbH
  • 12. Fountayn
  • 13. ICON PLC
  • 14. International Business Machines Corporation
  • 15. IQVIA Inc.
  • 16. KPS Life, LLC
  • 17. MaxisIT Inc.
  • 18. MedNet Solutions, Inc.
  • 19. Medrio, Inc.
  • 20. Microsoft Corporation
  • 21. Octalsoft
  • 22. Oracle Corporation
  • 23. Parexel International Corporation
  • 24. RealTime Software Solutions, LLC
  • 25. Research Solutions, Inc.
  • 26. Saama Technologies, LLC
  • 27. Signant Health
  • 28. Sitero
  • 29. Veeva Systems Inc.